Concussion, Intermediate
18
2
4
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (18)
Intervention to Change Affect Recognition and Empathy
Turkish Translation of SportsConcussion Assesment Tool 6
Facilitating Access to Specialty Treatment
Building Emotional Self-Awareness Teletherapy (BEST)
Magnesium and Riboflavin Treatment for Post-Concussion Headache
Assessment of the Effects of Concussion on Adolescent Rugby Union Players
Biomarkers in Concussion
Concussion Active Rehabilitation
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
Use of Adipose-Derived Stem/Stromal Cells in Concussion and Traumatic Brain Injuries
Assessment of Oculomotor, Vestibular and Reaction Time Response Following a Concussive Event
Objective Brain Function Assessment of mTBI/Concussion
Objective Brain Function Assessment of mTBI/Concussion in College Athletes
Validation of Brain Function Assessment Algorithm for mTBI/Concussion
Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes
Objective Brain Function Assessment of mTBI/Concussion in High School Athletes
Unblinded Data Collection Study of Concussion Using BrainPulse
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients